Mbiomics

News

Mbiomics: €30 million in the third Series A closing

Fresh funding for innovative therapeutics: Munich-based biotech startup Mbiomics secures capital for the further development of its microbiome therapies and is driving the…

Tubulis Exit, Munich

Startups

It all started with an email: The Tubulis story behind the 5 billion exit

In June 2016, Jonas Helma-Smets wrote an email. Politely worded, almost reserved. He introduced himself, explained his idea, and…

Onyx Biotech

News

Pre-seed funding for Onyx Biotech

Munich-based startup Onyx Biotech has secured a pre-seed funding round with the Life Science Valley Growth Fund, Freiraum Ventures, and several business angels…

Omegga Founding Team

News

Omegga receives 10 million euros in seed capital

Munich-based startup Omegga raises fresh capital to advance its technology for early sex determination in chicken eggs.

Rnatics

7 Questions

Rnatics: Hope for pulmonary fibrosis

Rnatics is developing RCS-21, a novel inhalable drug for pneumonia and idiopathic pulmonary fibrosis. The startup was founded in 2021 as a spin-off of…

Tubules

News

Tubules purchased from American pharmaceutical giant

Munich-based biotech unicorn Tubulis is being sold to US corporation Gilead for a billion-dollar sum.

Rnhale

7 Questions

Rnhale: Inhalable RNA for new therapies

Munich-based biotech startup Rnhale is developing inhalable RNA therapeutics as a dry powder – faster, simpler, and more efficient than previous approaches. This is intended to treat respiratory diseases…

Rnatics Engelhardt

News

A milestone in the treatment of lung diseases? Rnatics receives 2.7 million euros.

Munich-based biotech startup Rnatics has secured €2.7 million in federal funding. The funds will be used for the clinical development of a…

Twogee Biotech

Startups

Twogee Biotech: Valuable materials from biomass

Twogee Biotech transforms industrial waste into sustainable sugar, thus turning biomass by-products into a valuable raw material for the chemical and biotechnology industries.

Helge Jochens and Frank Wallrapp, founders of Twogee Biotech (Photo: Twogee Biotech)

News

Twogee Biotech raises €2.16 million

Munich-based startup Twogee Biotech has secured multi-million euro seed funding. The company will use the capital to accelerate the industrial application of…

Founder & CEO of 2NA Fish Dr. Christina Port & investors with Michael Adersberger, Managing Director and Investment Manager at Twip (left) and Fabian Hogrebe, Investment Manager at GF BRYCK Ventures (right)

News

2NA Fish receives fresh capital

Munich-based startup 2NA Fish secures another pre-seed investment to advance its spatial RNA biomarker detection platform.

Biovaria 2026

Competition

Biovaria launches new Pitch & Partner program 2026

Startups in the life sciences and biotechnology sectors, as well as founders, can now apply. Prize money of up to €2,000 and…